These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20595243)

  • 1. HLA genotyping in the international Type 1 Diabetes Genetics Consortium.
    Mychaleckyj JC; Noble JA; Moonsamy PV; Carlson JA; Varney MD; Post J; Helmberg W; Pierce JJ; Bonella P; Fear AL; Lavant E; Louey A; Boyle S; Lane JA; Sali P; Kim S; Rappner R; Williams DT; Perdue LH; Reboussin DM; Tait BD; Akolkar B; Hilner JE; Steffes MW; Erlich HA;
    Clin Trials; 2010; 7(1 Suppl):S75-87. PubMed ID: 20595243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collection and processing of whole blood for transformation of peripheral blood mononuclear cells and extraction of DNA: the Type 1 Diabetes Genetics Consortium.
    Rosinger S; Nutland S; Mickelson E; Varney MD; Boehm BO; Olsem GJ; Hansen JA; Nicholson I; Hilner JE; Perdue LH; Pierce JJ; Akolkar B; Nierras C; Steffes MW;
    Clin Trials; 2010; 7(1 Suppl):S65-74. PubMed ID: 20595244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).
    Hilner JE; Perdue LH; Sides EG; Pierce JJ; Wägner AM; Aldrich A; Loth A; Albret L; Wagenknecht LE; Nierras C; Akolkar B;
    Clin Trials; 2010; 7(1 Suppl):S5-S32. PubMed ID: 20603248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missingness in the T1DGC MHC fine-mapping SNP data: association with HLA genotype and potential influence on genetic association studies.
    James I; McKinnon E; Gaudieri S; Morahan G;
    Diabetes Obes Metab; 2009 Feb; 11 Suppl 1(Suppl 1):101-7. PubMed ID: 19143822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes.
    Bronson PG; Ramsay PP; Thomson G; Barcellos LF;
    Diabetes Obes Metab; 2009 Feb; 11 Suppl 1(Suppl 1):74-83. PubMed ID: 19143818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA Haplotypes In 250 Families: The Baylor Laboratory Results And A Perspective On A Core NGS Testing Model For The 17
    Askar M; Madbouly A; Zhrebker L; Willis A; Kennedy S; Padros K; Rodriguez MB; Bach C; Spriewald B; Ameen R; Shemmari SA; Tarassi K; Tsirogianni A; Hamdy N; Mossallam G; Hönger G; Spinnler R; Fischer G; Fae I; Charlton R; Dunk A; Vayntrub TA; Halagan M; Osoegawa K; Fernández-Viña M
    Hum Immunol; 2019 Nov; 80(11):897-905. PubMed ID: 31558329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos.
    Bugawan TL; Klitz W; Alejandrino M; Ching J; Panelo A; Solfelix CM; Petrone A; Buzzetti R; Pozzilli P; Erlich HA
    Tissue Antigens; 2002 Jun; 59(6):452-69. PubMed ID: 12445315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive human leukocyte antigen genotyping of patients with type 1 diabetes mellitus in Taiwan.
    Tung YC; Fann CS; Chang CC; Chu CC; Yang WS; Hwu WL; Chen PL; Tsai WY
    Pediatr Diabetes; 2018 Jun; 19(4):699-706. PubMed ID: 29383806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes.
    Bjørnvold M; Undlien DE; Joner G; Dahl-Jørgensen K; Njølstad PR; Akselsen HE; Gervin K; Rønningen KS; Stene LC
    Diabetologia; 2008 Apr; 51(4):589-96. PubMed ID: 18292987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity.
    Ilonen J; Kiviniemi M; Lempainen J; Simell O; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2016 Jul; 17 Suppl 22():8-16. PubMed ID: 27411431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Type 1 Diabetes Genetics Consortium.
    Rich SS; Concannon P; Erlich H; Julier C; Morahan G; Nerup J; Pociot F; Todd JA
    Ann N Y Acad Sci; 2006 Oct; 1079():1-8. PubMed ID: 17130525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.
    Cejkova P; Novota P; Cerna M; Kolostova K; Novakova D; Kucera P; Novak J; Andel M; Weber P; Zdarsky E
    Int J Immunogenet; 2008 Apr; 35(2):133-40. PubMed ID: 18279373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is HLA the cause of the high incidence of type 1 diabetes in the Canary Islands? Results from the Type 1 Diabetes Genetics Consortium (T1DGC).
    Santana Del Pino A; Medina-Rodríguez N; Hernández-García M; Nóvoa-Mogollón FJ; Wägner AM;
    Endocrinol Diabetes Nutr; 2017 Mar; 64(3):146-151. PubMed ID: 28440753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-efficient multiplex PCR for routine genotyping of up to nine classical HLA loci in a single analytical run of multiple samples by next generation sequencing.
    Ozaki Y; Suzuki S; Kashiwase K; Shigenari A; Okudaira Y; Ito S; Masuya A; Azuma F; Yabe T; Morishima S; Mitsunaga S; Satake M; Ota M; Morishima Y; Kulski JK; Saito K; Inoko H; Shiina T
    BMC Genomics; 2015 Apr; 16(1):318. PubMed ID: 25895492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci.
    Nejentsev S; Sjöroos M; Soukka T; Knip M; Simell O; Lövgren T; Ilonen J
    Diabet Med; 1999 Dec; 16(12):985-92. PubMed ID: 10656226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Pedigree-Based SNP Haplotype Method for Genomic Polymorphism and Genetic Studies.
    Vadva Z; Larsen CE; Propp BE; Trautwein MR; Alford DR; Alper CA
    Cells; 2019 Aug; 8(8):. PubMed ID: 31387299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the MHC fine mapping data.
    Brown WM; Pierce J; Hilner JE; Perdue LH; Lohman K; Li L; Venkatesh RB; Hunt S; Mychaleckyj JC; Deloukas P;
    Diabetes Obes Metab; 2009 Feb; 11 Suppl 1(0 1):2-7. PubMed ID: 19143809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new automated human leukocyte antigen genotyping strategy to identify DR-DQ risk alleles for celiac disease and type 1 diabetes mellitus.
    Lavant EH; Carlson JA
    Clin Chem Lab Med; 2009; 47(12):1489-95. PubMed ID: 19929553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrosequencing-based strategies for improved allele typing of human leukocyte antigen loci.
    Ringquist S; Styche A; Rudert WA; Trucco M
    Methods Mol Biol; 2007; 373():115-34. PubMed ID: 17185762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHC.
    Cheung YH; Watkinson J; Anastassiou D
    Hum Genet; 2011 Feb; 129(2):161-76. PubMed ID: 21076979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.